Invention Grant
- Patent Title: Deuterated tryptamine derivatives and methods of use
-
Application No.: US17974007Application Date: 2022-10-26
-
Publication No.: US11746088B2Publication Date: 2023-09-05
- Inventor: Alex Nivorozhkin , Michael Palfreyman
- Applicant: CYBIN IRL LIMITED
- Applicant Address: IE Dublin
- Assignee: CYBIN IRL LIMITED
- Current Assignee: CYBIN IRL LIMITED
- Current Assignee Address: IE Dublin
- Agency: Lathrop GPM LLP
- Agent Lisa Hillman
- Main IPC: C07D209/16
- IPC: C07D209/16 ; A61K9/20 ; A61K31/4045
Abstract:
The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor.
Public/Granted literature
- US20230066286A1 DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE Public/Granted day:2023-03-02
Information query
